Hikma Pharmaceuticals PLC (LON:HIK) to Issue Dividend of $0.48

Hikma Pharmaceuticals PLC (LON:HIK - Get Free Report) declared a dividend on Wednesday, February 26th, DividendData.Co.Uk reports. Stockholders of record on Thursday, March 20th will be given a dividend of $0.48 per share on Thursday, May 1st. This represents a dividend yield of 1.8%. The ex-dividend date of this dividend is Thursday, March 20th. This is a 50.0% increase from Hikma Pharmaceuticals's previous dividend of $0.32. The official announcement can be seen at this link.

Hikma Pharmaceuticals Stock Performance

Shares of Hikma Pharmaceuticals stock traded down GBX 2 ($0.03) on Friday, hitting GBX 2,020 ($26.08). The stock had a trading volume of 971,943 shares, compared to its average volume of 1,943,321. Hikma Pharmaceuticals has a 52-week low of GBX 1,750 ($22.60) and a 52-week high of GBX 2,360 ($30.47). The company has a current ratio of 1.66, a quick ratio of 1.27 and a debt-to-equity ratio of 55.82. The stock has a market cap of £5.60 billion, a price-to-earnings ratio of 19.82, a P/E/G ratio of 2.38 and a beta of 0.41. The company's 50 day moving average price is GBX 2,178.42 and its 200 day moving average price is GBX 2,015.75.

Analysts Set New Price Targets

HIK has been the subject of several analyst reports. JPMorgan Chase & Co. reaffirmed an "overweight" rating on shares of Hikma Pharmaceuticals in a research note on Friday, March 7th. Berenberg Bank reissued a "buy" rating and set a GBX 2,560 ($33.05) target price on shares of Hikma Pharmaceuticals in a research note on Monday, March 10th.

Remove Ads

Hikma Pharmaceuticals Company Profile

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.